Compare BFAM & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BFAM | IRON |
|---|---|---|
| Founded | 1986 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.1B |
| IPO Year | 2012 | 2020 |
| Metric | BFAM | IRON |
|---|---|---|
| Price | $67.09 | $69.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $114.57 | $103.18 |
| AVG Volume (30 Days) | ★ 659.6K | 440.1K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.00 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $1,903,182,000.00 | N/A |
| Revenue This Year | $8.19 | N/A |
| Revenue Next Year | $5.83 | $283.52 |
| P/E Ratio | $48.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $57.63 | $40.00 |
| 52 Week High | $112.41 | $99.50 |
| Indicator | BFAM | IRON |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 29.31 |
| Support Level | $63.89 | $64.48 |
| Resistance Level | $78.95 | $71.85 |
| Average True Range (ATR) | 2.17 | 3.07 |
| MACD | -0.41 | -1.50 |
| Stochastic Oscillator | 40.26 | 11.41 |
Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; Full-service center-based child care, Backup care, and Educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.